I-131 Avid Versus FDG avid Loco-Regional Recurrent Differentiated Thyroid Carcinoma;Clinic-Pathological, Diagnostic & Therapy Outcome Differences
Talaat, O. (2015). I-131 Avid Versus FDG avid Loco-Regional Recurrent Differentiated Thyroid Carcinoma;Clinic-Pathological, Diagnostic & Therapy Outcome Differences. EKB Journal Management System, 11(11), 62-74. doi: 10.21608/egyjnm.2015.5449
Omnia Talaat. "I-131 Avid Versus FDG avid Loco-Regional Recurrent Differentiated Thyroid Carcinoma;Clinic-Pathological, Diagnostic & Therapy Outcome Differences". EKB Journal Management System, 11, 11, 2015, 62-74. doi: 10.21608/egyjnm.2015.5449
Talaat, O. (2015). 'I-131 Avid Versus FDG avid Loco-Regional Recurrent Differentiated Thyroid Carcinoma;Clinic-Pathological, Diagnostic & Therapy Outcome Differences', EKB Journal Management System, 11(11), pp. 62-74. doi: 10.21608/egyjnm.2015.5449
Talaat, O. I-131 Avid Versus FDG avid Loco-Regional Recurrent Differentiated Thyroid Carcinoma;Clinic-Pathological, Diagnostic & Therapy Outcome Differences. EKB Journal Management System, 2015; 11(11): 62-74. doi: 10.21608/egyjnm.2015.5449